Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Soukupova

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Nanotechnology|May 7, 2009
Comment on 'Preparation and antibacterial activity of Fe3O4@Ag nanoparticles'Libor Kvítek, Jana Soukupova
Neuromolecular Medicine|August 12, 2011
Characterisation of ATM mutations in Slavic Ataxia telangiectasia patientsJana Soukupova, Petr Pohlreich, Eva Seemanova
European Journal of Cancer (Oxford, England : 1990)|April 25, 2021
Re: ERCC3, a new ovarian cancer susceptibility gene?Jana Soukupova, Petra Zemankova, Petr Nehasil, et al.
Oncology Reports|May 24, 2008
Contribution of mutations in ATM to breast cancer development in the Czech populationJana Soukupova, Pavel Dundr, Zdenek Kleibl, et al.
International Journal of Molecular Sciences|December 9, 2023
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Klara Horackova, Marketa Janatova, Petra Kleiblova, et al.
Journal of Cancer Research and Therapeutics|July 20, 2023
BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinductionMichal Zikan, Livia Vecerova, Olga Dubova, et al.
Cancer Biomarkers : Section a of Disease Markers|April 12, 2024
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancerKlara Horackova, Michal Vocka, Sarka Lopatova, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 23, 2016
Microscale Rockets and Picoliter Containers Engineered from Electrospun Polymeric MicrotubesAmit Sitt, Jana Soukupova, David Miller, et al.
Plos One|August 8, 2014
Silver nanoparticles modified by gelatin with extraordinary pH stability and long-term antibacterial activityMartin Sivera, Libor Kvitek, Jana Soukupova, et al.
Cells|December 16, 2020
<i>CHEK2</i> Germline Variants in Cancer Predisposition: Stalemate Rather than CheckmateLenka Stolarova, Petra Kleiblova, Marketa Janatova, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Nanotechnology|May 7, 2009
Comment on 'Preparation and antibacterial activity of Fe3O4@Ag nanoparticles'Libor Kvítek, Jana Soukupova
Neuromolecular Medicine|August 12, 2011
Characterisation of ATM mutations in Slavic Ataxia telangiectasia patientsJana Soukupova, Petr Pohlreich, Eva Seemanova
European Journal of Cancer (Oxford, England : 1990)|April 25, 2021
Re: ERCC3, a new ovarian cancer susceptibility gene?Jana Soukupova, Petra Zemankova, Petr Nehasil, et al.
Oncology Reports|May 24, 2008
Contribution of mutations in ATM to breast cancer development in the Czech populationJana Soukupova, Pavel Dundr, Zdenek Kleibl, et al.
International Journal of Molecular Sciences|December 9, 2023
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Klara Horackova, Marketa Janatova, Petra Kleiblova, et al.
Journal of Cancer Research and Therapeutics|July 20, 2023
BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinductionMichal Zikan, Livia Vecerova, Olga Dubova, et al.
Cancer Biomarkers : Section a of Disease Markers|April 12, 2024
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancerKlara Horackova, Michal Vocka, Sarka Lopatova, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 23, 2016
Microscale Rockets and Picoliter Containers Engineered from Electrospun Polymeric MicrotubesAmit Sitt, Jana Soukupova, David Miller, et al.
Plos One|August 8, 2014
Silver nanoparticles modified by gelatin with extraordinary pH stability and long-term antibacterial activityMartin Sivera, Libor Kvitek, Jana Soukupova, et al.
Cells|December 16, 2020
<i>CHEK2</i> Germline Variants in Cancer Predisposition: Stalemate Rather than CheckmateLenka Stolarova, Petra Kleiblova, Marketa Janatova, et al.
Pageof 5